On 24 November 2026, Derodes Partners and PSCC are hosting a 2-hour executive webinar: "Accelerate Global Clinical Development with ASIA-PACIFIC (APAC)".

Clinical development is being redrawn. According to the IQVIA Institute (Global R&D Trends 2026), Western Europe is still the most-used region for clinical trials, but its share of trial country use has dropped 17% since 2019. Asia-Pacific (APAC) keeps gaining ground, and deals between China-based and international biopharma companies hit an all-time high in 2025.

       Why integrate APAC into your clinical development plan?
       
      How to partner with the region?

For European biotechs, the question has shifted from whether to include APAC to how and when.

We will focus on oncology and bring together industry and academic views from the region:

Pramod Kashid, CEO, Expecto Health Sciences (part of Southern Star Research), a CRO operating across Asia, Australia and New Zealand

Dr Mitsumi Terada, MD, PhD, Section Head, Asian Partnerships Section, Department of International Clinical DevelopmentNational Cancer Center Hospital, Japan

Prof Ravindran Kanesvaran, Co-Director at Singapore Translational Cancer Consortium (STCC), Chairman and Senior Consultant, Division of Medical Oncology National Cancer Centre Singapore